Vision problems are often dismissed as simple eye strain, fatigue, or the need for a new pair of glasses. But in some cases, sudden blurred vision, pain behind the eyes, or difficulty seeing colours ...

The FDA agreed that the design of a Phase 3 trial testing privosegtor in optic neuritis could support a future approval application.

Multiple sclerosis (MS), a multifaceted condition influenced by both genetic and environmental factors, remains a complex diagnostic enigma, especially for diverse populations such as the Hispanic ...

Genetic analysis combined with consideration of other risk factors could significantly improve early distinction between people with optic neuritis who are likely to develop multiple sclerosis (MS), ...

"Our decision to treat typically needs to be made on the balance of likelihood, before the diagnosis of an associated disease process can be fully established, with definitive tests for multiple ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Fampridine resulted in no significant observed ...

A new therapeutic agent tested in a mouse model of multiple sclerosis (MS) produced anti-inflammatory activity and prevented loss of cells in the optic nerve, according to a new study by researchers ...

The results of research led by scientists at the University of Exeter, and at King’s College London, suggests that young people could be spared from going blind by a new genetic risk tool that could ...

Neuroimaging has become indispensable in the diagnosis and monitoring of optic neuritis and multiple sclerosis (MS), two disorders characterised by inflammatory demyelination and neuronal injury ...

Optic Neuritis: Clinical Features Optic neuritis refers to inflammation of the optic nerve. The term may be used broadly in reference to many causes of optic nerve inflammation including systemic ...